Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

Press releases published on July 23, 2026

41 minutes ago

20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock

Indeterminate GlobeNewswire

42 minutes ago

Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays

Indeterminate GlobeNewswire

42 minutes ago

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026

Indeterminate GlobeNewswire

42 minutes ago

Cato Supply Rebrands as Cato Healthcare Supply to Reflect Expanded Mission of Protecting Hospital Revenue Through Supply Chain Resilience

Indeterminate GlobeNewswire

42 minutes ago

ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center

Indeterminate GlobeNewswire

42 minutes ago

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire

42 minutes ago

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

Indeterminate GlobeNewswire

42 minutes ago

NewGen’s Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai’s Valuation Reaches US$200 Million

Indeterminate GlobeNewswire

an hour ago

CRB Names Joe Finsterwald Chief Technology Officer

Indeterminate GlobeNewswire

an hour ago

Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

an hour ago

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

an hour ago

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

Indeterminate GlobeNewswire

an hour ago

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Indeterminate GlobeNewswire

an hour ago

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

Indeterminate GlobeNewswire

an hour ago

Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201

Indeterminate GlobeNewswire

an hour ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

an hour ago

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Indeterminate GlobeNewswire

an hour ago

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

Indeterminate GlobeNewswire

an hour ago

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Indeterminate GlobeNewswire

an hour ago

Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions

Indeterminate GlobeNewswire